Cartesian Therapeutics, Inc. Warrants and Rights Outstanding
Cartesian Therapeutics, Inc. (RNAC) had Warrants and Rights Outstanding of $165.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-08-06
- 2026-06-30: Warrants and Rights Outstanding $165.00K.
- 2026-03-31: Warrants and Rights Outstanding $47.00K.
- 2025-12-31: Warrants and Rights Outstanding $141.00K.
- 2025-09-30: Warrants and Rights Outstanding $848.00K.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2026-06-30 | $165.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $47.00K 10-Q · filed 2026-04-30 |
| 2025-12-31 | $141.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $848.00K 10-Q · filed 2025-11-06 |
| 2024-12-31 | $3.84M 10-K · filed 2026-03-09 |
| 2023-09-30 | $13.09M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $16.88M 10-Q · filed 2023-08-17 |
| 2023-03-31 | $23.22M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $19.14M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $33.47M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $26.93M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $6.91M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $25.42M 10-K · filed 2023-03-02 |
| 2021-09-30 | $40.04M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $40.63M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $45.45M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $28.71M 10-K · filed 2022-03-10 |
| 2020-09-30 | $25.43M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $32.77M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $42.40M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $41.55M 10-K · filed 2021-03-12 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |